Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2845.97 | 1445 / 1445 | 100% | 95.35 | 183 / 183 |
stomach | 100% | 2200.25 | 359 / 359 | 100% | 70.93 | 286 / 286 |
lung | 100% | 4725.02 | 578 / 578 | 100% | 154.29 | 1154 / 1155 |
ovary | 100% | 2517.30 | 180 / 180 | 100% | 59.61 | 429 / 430 |
intestine | 100% | 3298.68 | 966 / 966 | 100% | 81.14 | 525 / 527 |
uterus | 100% | 2215.13 | 170 / 170 | 100% | 98.96 | 457 / 459 |
brain | 100% | 1526.64 | 2631 / 2642 | 100% | 76.61 | 704 / 705 |
prostate | 100% | 2900.81 | 245 / 245 | 99% | 73.52 | 499 / 502 |
breast | 100% | 3123.86 | 459 / 459 | 99% | 111.71 | 1110 / 1118 |
thymus | 100% | 2573.52 | 652 / 653 | 99% | 59.19 | 597 / 605 |
bladder | 100% | 2718.71 | 21 / 21 | 98% | 89.05 | 494 / 504 |
liver | 100% | 2010.26 | 226 / 226 | 98% | 84.22 | 397 / 406 |
skin | 100% | 2554.38 | 1809 / 1809 | 97% | 85.11 | 458 / 472 |
adrenal gland | 100% | 8650.24 | 258 / 258 | 97% | 86.45 | 223 / 230 |
kidney | 100% | 1752.78 | 89 / 89 | 95% | 39.82 | 852 / 901 |
pancreas | 94% | 936.69 | 307 / 328 | 99% | 65.26 | 176 / 178 |
spleen | 100% | 1309.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 74.30 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.55 | 1 / 1 |
blood vessel | 100% | 2295.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2528.04 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1791.82 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1333.01 | 838 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 32.02 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 83% | 36.29 | 66 / 80 |
peripheral blood | 59% | 864.19 | 547 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0008104 | Biological process | protein localization |
GO_0046512 | Biological process | sphingosine biosynthetic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0017059 | Cellular component | serine palmitoyltransferase complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
GO_0004758 | Molecular function | serine C-palmitoyltransferase activity |
Gene name | SPTSSA |
Protein name | Serine palmitoyltransferase small subunit A (Small subunit of serine palmitoyltransferase A) (ssSPTa) |
Synonyms | SSSPTA C14orf147 |
Description | FUNCTION: Component of the serine palmitoyltransferase multisubunit enzyme (SPT) that catalyzes the initial and rate-limiting step in sphingolipid biosynthesis by condensing L-serine and activated acyl-CoA (most commonly palmitoyl-CoA) to form long-chain bases . The SPT complex is composed of SPTLC1, SPTLC2 or SPTLC3 and SPTSSA or SPTSSB. Within this complex, the heterodimer consisting of SPTLC1 and SPTLC2/SPTLC3 forms the catalytic core . Within the SPT complex, SPTSSA stimulates the catalytic activity and plays a role in substrate specificity, which depends upon the overall complex composition . The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SPTSSA isozyme uses both C14-CoA and C16-CoA as substrates, with a slight preference for C14-CoA . Independently of its action as a SPT component, may be involved in MBOAT7 localization to mitochondria-associated membranes, a membrane bridge between the endoplasmic reticulum and mitochondria, may hence affect MBOAT7-catalyzed incorporation of arachidonic acid into phosphatidylinositol . . |
Accessions | ENST00000298130.5 Q969W0 |